Formulation and Characterization of Edoxaban-Loaded Solid Lipid Nanoparticles
DOI:
https://doi.org/10.63682/jns.v14i30S.6936Keywords:
Formulation, Characterization, Solid Lipid Nanoparticles, Anticoagulant Drug and EdoxabanAbstract
To produce solid lipid nanoparticles of Edoxaban to increase pharmacokinetics and anticoagulant efficacy in rats. Edoxaban-loaded solid lipid nanoparticles were optimized using the central composite architecture. Particle size and %EE were dependent factors, whereas medication, lipid, and surfactant concentrations were independent variables. The optimized Edo-SLN projected particle size, %EE, and PDI values, which matched the actual values. DSC findings validated the drug's amorphous state in the optimized Edo-SLN, whereas TEM data revealed nanodispersion and spherical particle shape. Drug burst and sustained release were seen in the formulations. Pharmacokinetic studies demonstrated that optimized Edoxaban formulations had higher bioavailability than simple drug solution. Better body weight and lower fasting blood glucose were seen with optimized Edo-SLN than with standard medication suspension. Edoxaban-loaded SLN were effectively synthesized and managed anticoagulant activity well. Data suggests SLN may improve Edoxaban bioavailability for anticoagulant treatment. They lower dose frequency compared to traditional dosage forms, improving patient compliance. These may be used to reduce blood clotting in the future..
Downloads
References
Patra JK, Das G, Fraceto LF, Campos EV, Rodriguez-Torres MD, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S. Nano based drug delivery systems: recent developments and future prospects. Journal of nanobiotechnology. 2018 Dec;16:1-33.
Talele P, Jadhav A, Sahu S, Shimpi N. Experimental approaches to evaluate solid lipid nanoparticle-based drug delivery systems. Analytical Methods. 2025.
Samee A, Usman F, Wani TA, Farooq M, Shah HS, Javed I, Ahmad H, Khan R, Zargar S, Kausar S. Sulconazole-loaded solid lipid nanoparticles for enhanced antifungal activity: in vitro and in vivo approach. Molecules. 2023 Nov 9;28(22):7508.
Nasseri M, Golmohammadzadeh S, Arouiee H, Jaafari MR, Neamati H. Antifungal activity of Zataria multiflora essential oil-loaded solid lipid nanoparticles in-vitro condition. Iranian Journal of Basic Medical Sciences. 2016 Nov;19(11):1231.
Bahari LA, Hamishehkar H. The impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers; a comparative literature review. Advanced pharmaceutical bulletin. 2016 Jun 30;6(2):143.
Arabestani MR, Bigham A, Kamarehei F, Dini M, Gorjikhah F, Shariati A, Hosseini SM. Solid lipid nanoparticles and their application in the treatment of bacterial infectious diseases. Biomedicine & Pharmacotherapy. 2024 May 1;174:116433. DOI: 10.1016/j.biopha.2024.116433
Huang X, Chen YJ, Peng DY, Li QL, Wang XS, Wang DL, Chen WD. Solid lipid nanoparticles as delivery systems for Gambogenic acid. Colloids and Surfaces B: Biointerfaces. 2013 Feb 1;102:391-7. DOI: 10.1016/j.colsurfb.2012.08.058
Mishra V, Bansal KK, Verma A, Yadav N, Thakur S, Sudhakar K, Rosenholm JM. Solid lipid nanoparticles: Emerging colloidal nano drug delivery systems. Pharmaceutics. 2018 Oct 18;10(4):191.
Rahmanian-Devin P, Askari VR, Sanei-Far Z, Rahimi VB, Kamali H, Jaafari MR, Golmohammadzadeh S. Preparation and characterization of solid lipid nanoparticles encapsulated noscapine and evaluation of its protective effects against imiquimod-induced psoriasis-like skin lesions. Biomedicine & Pharmacotherapy. 2023 Dec 1;168:115823.
Bhatt R, Singh D, Prakash A, Mishra N. Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington’s disease. Drug delivery. 2015 Oct 3;22(7):931-9. DOI: 10.3109/10717544.2014.880860
Sangeetha S. Formulation Design, Optimization, and Evaluation of Solid Lipid Nanoparticles Loaded with an Antiviral Drug Tenofovir Using Box–Behnken Design for Boosting Oral Bioavailability. Advances in Pharmacological and Pharmaceutical Sciences. 2024 Dec 31;2024:5248746.
Dhiman S, Singh TG, Anand S, Yadav P. Formulation and Evaluation of Solid Lipid Nanoparticles for controlled delivery of Zidovudine. Research Journal of Pharmacy and Technology. 2021;14(5):2548-56. DOI: 10.52711/0974-360X.2021.00449
Duong VA, Nguyen TT, Maeng HJ. Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method. Molecules. 2020 Oct 18;25(20):4781.
Attia D, El-Housiny S, Atef Shams Eldeen M, Ahmed El-Attar Y, Salem H, Bendas E, El-Nabarawi M. Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study.
Shazly GA. Ciprofloxacin controlled‐solid lipid nanoparticles: characterization, in vitro release, and antibacterial activity assessment. BioMed research international. 2017;2017(1):2120734.
Begum M, Shaik NB. Formulation and evaluation of linezolid loaded solid lipid nanoparticles as topical gel. Int J Pharm Sci. 2020;11:4924-33.
Chettupalli AK, Bukke SP, Rahaman SA, Unnisa A, Adepu M, Kavitha M, Babu MR, Narapureddy BR, Onohuean H. Ritonavir loaded solid lipid nanoparticles for oral drug delivery and bioavailability enhancement. Discover Applied Sciences. 2025 Jan 7;7(1):58. DOI: 10.1007/s42452-024-06322-1
Jain NK, Ram A. Development and characterization of nanostructured lipid carriers of oral hypoglycemic agent: selection of surfactants. Int J Pharm Sci Rev Res. 2011;7(2):125-30.
Zhao W, Zeng M, Li K, Pi C, Liu Z, Zhan C, Yuan J, Su Z, Wei Y, Wen J, Pi F. Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo. Pharmaceutical Biology. 2022 Dec 31;60(1):2300-7.
Jamous YF, Altwaijry NA, Saleem MT, Alrayes AF, Albishi SM, Almeshari MA. Formulation and characterization of solid lipid nanoparticles loaded with troxerutin. Processes. 2023 Oct 23;11(10):3039.
Soma D, Attari Z, Reddy MS, Damodaram A, Koteshwara KB. Solid lipid nanoparticles of irbesartan: preparation, characterization, optimization and pharmacokinetic studies. Brazilian Journal of Pharmaceutical Sciences. 2017 Apr 20;53:e15012.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
